Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
NCT07045935
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Prolactinoma
Interventions
DRUG:
Cabergoline (Dopamine Agonist)
Sponsor
University Hospital, Basel, Switzerland